Boers, Jorianne
de Vries, Erik F. J.
Glaudemans, Andor W. J. M.
Hospers, Geke A. P.
Schröder, Carolina P. http://orcid.org/0000-0001-7537-489X
Funding for this research was provided by:
University Medical Center Groningen
Article History
First Online: 6 July 2020
Compliance with ethical standards
:
: Jorianne Boers, Andor W.J.M. Glaudemans and Carolina P. Schröder declare no conflict of interest. Erik F.J. de Vries has received research funding through grants from ZonMw (for PET imaging of T cells in patients with cancer), the Dutch Cancer Foundation (KWF) (for PET imaging of T cells in patients with cancer), and ZonMw/MS Research Foundation (for validation of novel tracer for PET imaging of myelin); has assisted in conducting contracted research studies funded by Rodin Therapeutics (for PET imaging of the brain in health volunteers and patients with Alzheimer's Disease), Lysosomal Therapeutics Ltd. (for PET imaging of the brain in patients with Parkinson's Disease), Hoffmann-La Roche (for dosimetry of a tracer in rats), and Ionis Pharmaceuticals (for PET imaging in patients with Alzheimer's Disease). Geke A.P. Hospers has received research funding from The Seerave Foundation and Bristol-Myers Squibb, and has served in a consulting/advisory role for Bristol-Myers Squibb, MSD, Novartis, Pierre Fabre, and Roche.
: This article does not contain any studies with human or animal subjects performed by any of the authors.